Market Overview

Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Share:
Related TRIB
Earnings Scheduled For March 14, 2017
10 Stocks With Highest Close In Three Weeks
Related VIVO
15 Biggest Mid-Day Losers For Wednesday
Mid-Afternoon Market Update: Seagate Climbs On Strong Q2 Results; Meridian Bioscience Shares Plummet
Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year —…–8 Operating ... (GuruFocus)

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is 5.89%.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 19.23%. Meridian Bioscience's revenue for the same period is $173.54 million.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.50%. IDEXX Laboratories' PEG ratio is 1.91.

The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.35%. Neogen's ROE for the same period is 10.90%.

Posted-In: Diagnostic Substances Industry Highest Profit MarginTrading Ideas

 

Related Articles (IDXX + NEOG)

View Comments and Join the Discussion!